Hazard Information | Back Directory | [in vivo]
Samuraciclib (ICEC0942; 100 mg/kg; oral gavage; daily; for 14 days; female nu/nu-BALB/c athymic nude mice) treatment inhibits tumor growth by 60% at day 14, and is accompanied by highly significant reductions in PolII Ser2 and Ser5 phosphorylation in PBMCs and in tumors[1].
The combination of Samuraciclib (ICEC0942) and ICI 47699 treatment shows complete growth arrest of estrogen receptor (ER)-positive tumor xenografts[1]. Animal Model: | Female nu/nu-BALB/c athymic nude mice (7-week old) with MCF7 cells[1]. | Dosage: | 100 mg/kg | Administration: | Oral gavage; daily; for 14 days | Result: | At day 14, tumor growth was inhibited by 60%. |
| [IC 50]
CDK7/CycH/MAT1: 41 nM (IC50); CDK2/cycE1: 578 nM (IC50); CDK1: 1.8 μM (IC50); CDK4: 49 μM (IC50); CDK5: 9.4 μM (IC50); CDK6: 34 μM (IC50); CDK9: 1.2 μM (IC50) |
|
Company Name: |
Cool Pharm, Ltd
|
Tel: |
021-58581007 18019463053 |
Website: |
http://www.coolpharm.com |
Company Name: |
BOC Sciences
|
Tel: |
16314854226 |
Website: |
www.bocsci.com |
Company Name: |
DC Chemicals
|
Tel: |
021-58447131 13564518121 |
Website: |
http://m.is0513.com/ShowSupplierProductsList927327/0.htm |
Company Name: |
cjbscvictory
|
Tel: |
13348960310 13348960310 |
Website: |
https://www.weikeqi-biotech.com/ |
Company Name: |
Enzo Biochem Inc
|
Tel: |
Enzo Biochem Inc. 13797054060 |
Website: |
www.enzo.com |
|